ATTRIVA
ATTRIVA
Industry:
Advertising Marketing
Address:
Sydney, New South Wales, Australia
Country:
Australia
Website Url:
http://www.attriva.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Amazon JsDelivr Cloudflare JS Google Amazon Virginia Region Amazon SSL WordPress 6.3 Intercom Help Loom Skilljar
Similar Organizations
Current Employees Featured
Official Site Inspections
http://www.attriva.com
- Host name: cdn-185-199-108-153.github.com
- IP address: 185.199.108.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Attriva"
Attriva - Google Analytics Cost Uploader
Attriva is now Vendo. To see new sources and destinations visit . VendoData.com. Data Integration Simplified Attriva collects, transforms and syncs your ad data with Google …See details»
Attriva - Crunchbase Company Profile & Funding
Attriva is an advertising & marketing industry. Start Free Trial . Chrome ExtensionSee details»
Attriva - Company Profile - Tracxn
Oct 18, 2024 Attriva ranks 61st among 61 competitors. 6 of its competitors are funded while 4 have exited. Overall, Attriva and its competitors have raised over $28.6M in funding across 12 …See details»
Attriva - Overview, News & Competitors | ZoomInfo.com
Attriva Attriva collects, transforms and syncs your ad data with Google Analytics Less data wrangling and more analysis Save time, analyse ROI accurately with: Smart UTM Matching …See details»
Biocure Technology Inc. enters into exclusive Letter Agreement to ...
Sep 18, 2023 Neither the Canadian Securities Exchange (the “CSE”) nor the Investment Industry Regulatory Organization of Canada) accepts responsibility for the adequacy or …See details»
Attriva - Product Information, Latest Updates, and Reviews 2024 ...
With Attriva, you can sync your advertising data from Facebook, Instagram and Microsoft Ads with Google Analytics. When all your ad data is in Google Analytics, you can analyse your …See details»
Atriva Therapeutics Announces Exclusive Letter Agreement for …
Sep 18, 2023 Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology. 18.09.2023 19.09.2023; 4 min readSee details»
Attriva - Facebook
Attriva. 853 likes · 1 talking about this. Advertising/MarketingSee details»
Attriva - Medium
Oct 9, 2019 Attriva Information and software for Data Driven Marketers. Follow. How to sync your advertising data from Facebook and Microsoft Ads to Google Analytics automatically.See details»
Atriva Therapeutics Announces Exclusive Letter Agreement for …
Sep 18, 2023 Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction. Upon successful completion of …See details»
Atriva Therapeutics | Atriva
The Atriva Approach First-in-class host-targeting therapies to treat infections caused for example by influenza viruses, respiratory syncytial virus, dengue fever virus and hanta virus.See details»
Atriva Therapeutics - Crunchbase Company Profile & Funding
Atriva Therapeutics may be growing as evidenced by its involvement in a significant corporate transaction. The company has entered into an exclusive letter agreement for a reverse …See details»
Atriva Therapeutics appoints Christian Pangratz as Chief Executive ...
Jan 16, 2023 Atriva Therapeutics appoints Christian Pangratz as Chief Executive Officer, implementing planned management change. 16.01.2023 17.01.2023; 5 min readSee details»
Atriva Therapeutics GmbH - LinkedIn
Atriva Therapeutics GmbH Biotechnology Research Planegg/Martinsried, Bavaria 1,850 followers Clinical stage biopharmaceutical company spearheading antiviral drug innovationSee details»
Atriva Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
Atriva Therapeutics, founded in 2015, is a biopharmaceutical company specifically pioneering the development of host-targeting antiviral therapies set up by a team of leading scientists in viral …See details»
Search - Innovations- und Gründerzentrum Biotechnologie IZB
Atriva Therapeutics GmbH, with additional sites in Tübingen and Frankfurt am Main, Germany, is pursuing a novel approach to combating known and unknown viral respiratory infectious …See details»
Atriva Therapeutics: a quantum leap in antiviral respiratory therapies
Atriva Therapeutics. Rainer Lichtenberger, President and CEO, Atriva Therapeutics GmbH, Tübingen, Germany, Tel: +49 7071 859 7673, www.atriva-therapeutics.comSee details»
Company | Atriva - Atriva Therapeutics
About us Atriva Therapeutics – When prevention fails: host-targeting therapy for severe viral disease. Atriva Therapeutics is a biopharmaceutical company pioneering the development of …See details»
The Atriva Approach | Atriva - Atriva Therapeutics
The company’s lead drug candidate is the MEK inhibitor zapnometinib. The small molecule, which can be administered orally (tablet), successfully completed Phase 2a development in COVID …See details»
Indications | Atriva - Atriva Therapeutics
Further potential indications . Both, antiviral and immunomodulatory properties make zapnometinib effective in successfully treating influenza viruses, SARS-CoV-2, and potentially …See details»